Praziquantel synergistically enhances paclitaxel efficacy to inhibit cancer cell growth.

The major challenges we are facing in cancer therapy with paclitaxel (PTX) are the drug resistance and severe side effects. Massive efforts have been made to overcome these clinical challenges by combining PTX with other drugs. In this study, we reported the first preclinical data that praziquantel...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zhen Hua Wu, Ming-ke Lu, Long Yu Hu, Xiaotong Li
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/3b14f78475d74842a0f671bc4c06ff69
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares